Pharmacogenomics Market Size is Estimated to grow at a CAGR of during the forecast period
The pharmacogenomics market is
anticipated to reach USD XXX.X million by 2030 from USD XXX.X million in 2022,
at a CAGR of XX.X% during the forecast period.
Because pharmacogenomics depends on the development of
genomic technologies, a wide range of therapeutic applications, and significant
investments in precision medicine initiatives, the field's future is quite
promising. As the industry progresses, cooperation between various players,
regulatory agencies' backing, and the construction of healthcare infrastructure
will all be crucial to the market's future growth throughout the 2023–2030
projection period.
The healthcare system faces significant challenges as a
result of adverse drug reactions (ADRs), which increase patient morbidity and
mortality as well as healthcare expenses. By identifying patients with a higher
propensity, pharmacogenomics testing lowers the likelihood of harmful
drug-related responses.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/pharmacogenomics-market
Growth Drivers:
One of the primary causes driving demand for
pharmacogenomics-based products is the prevalence of chronic diseases, which
mostly include cancer, neurological disorders, and cardiovascular disorders.
Chronic illnesses continue to burden healthcare systems around the world,
necessitating the development of more effective, focused treatments.
Pharmacogenomics offers the prospect of utilizing each patient's unique genetic
makeup to tailor medication in an effort to improve outcomes, increase patient
safety, and save unnecessary expenses related to ineffective medications.
Generic biomarkers, therapeutic targets, and drug-response
pathways have been discovered through scientific collaborations between
academia, industry, and government agencies; these discoveries have been made
possible by the substantial financial investments made by the biotechnology and
pharmaceutical industries in pharmacogenomics research and development.
The rapidly developing field of genomic technology is one
of the main drivers of the global pharmacogenomics market
expansion. Advances in NGS, microarrays, and PCR have significantly improved
the accuracy, speed, and cost-effectiveness of genetic diagnostics.
Pharmacogenomics
Segmentation:
By Product & Services:
· Kits
& Reagents
o PCR Kits & Reagents
o Sequencing Kits &
Reagents
o Microarray Kits &
Reagents
o Other Kits & Reagents
· Services
By Technology:
· PCR
· Microarray
· Sequencing
· Other
Technologies
By Disease:
· Cardiovascular
· Cancer
· Neurological
Diseases
· Others
By Application:
· Clinical
Research
· Personalized
Medicine
· Drug
Discovery & Preclinical Development
By End-User:
· Contract
Research Organizations
· Pharmaceutical
& Biotechnology Companies
· Academic
& Research Institutes
By Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
Key Companies
in Pharmacogenomics Market:
The research report
offers a competitive analysis of prominent companies operating in the pharmacogenomics
market. Some of the leading
players profiled in the market research report include:
· Illumina,
Inc.
· Thermo
Fisher Scientific, Inc.
· QIAGEN
· DH
Life Sciences, LLC.
· Laboratory
Corporation of America® Holdings.
· Eurofins
Scientific
· Charles
River Laboratories
· Bio-Rad
Laboratories, Inc.
· Agilent
Technologies, Inc.
· Revvity
· Medpace,
Inc.
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/pharmacogenomics-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment